EMPA-REG Kidney Visual Abstract While empagliflozin was the first out with a CVOT, canagliflozin was the first to complete a kidney-focused flozin trial, CREDENCE, which convincingly answered any doubts from the earlier trials
Consume caffeine and alcohol in small quantities, or opt for alternatives such as herbal teas and water with a splash of sugar-free cordial. 5
3X the benefits: Semaglutide (Ozempic and Wegovy) gained immense popularity for its ability to provide weight loss, reduced appetite, and stabilized insulin release, for sustained weight loss
Its a big deal with 500 million obese people worldwide
When to Startand When Not To According to the package insert, GLP-1 therapy for obesity is indicated for individuals with a BMI 27 with a weight-related condition, or a BMI 30 alone
During this washout period, the medication continues to exert diminishing effects